Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Aesthetic Business as Usual Amid COVID-19
Dr. Randolph Waldman shares details about his overall high patient retention rate and continuing demand for procedures during the ongoing COVID-19 pandemic.
The aesthetic industry was gripped by fears of a financial fallout as a result of COVID-19, but those fears were unfounded in his practice, according to Randolph Waldman, MD.
In this interview with Aesthetic Authority, Dr. Waldman discusses unpredicted levels of patient retention in his practice and others around the country.
Unlike many other specialties, aesthetic medicine is continuing to experience a steady stream of patients for surgical and nonsurgical procedures during the pandemic.
Related Videos
Related Content
